作者: Shigeyuki Sasaki , Yoshiro Matsui
DOI:
关键词:
摘要: Surgical interventions for ischemic or non-ischemic heart failure refractory to medical treatment include the implantation of an artificial heart, tissue engineering medicine, and myocardial substitute, in addition conventional coronary revascularization disease (IHD) undersized mitral annuloplasty (UMAP) functional regurgitation (FMR) causing damage. Remarkable progresses have been made these surgical methods, but they not necessarily reached a satisfactory level clinical application. Cardiac transplantation, final option failure, has standard procedure especially Japan, mainly due shortage donors, despite number efforts make it so far by personnel other parties concerned. Ischemic cardiomyopathy (ICM) non-ICM is myocardium per se; thus cardiac transplantation would be methods severely dilated treatment. However, restore native functions are often effective those with extremely low function. Although longterm prognosis procedures undetermined, considered important treatment, at least as alternative biologic bridge implantation. Left Ventricular Reconstruction Severely Dilated Heart